FindTrial
Sign In

A Study for assessing Pain relief with IV Morphine Titration Pain Protocol in cancer patients with severe pain in Emergency Department

An Observational Study for assessing the Effectiveness of IV Morphine Titration Pain Protocol in control of Cancer Pain in Emergency Department

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/08/015181
Enrollment
40
Registered
2018-08-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

None listed

Sponsors

Tata Memorial Hospital Mumbai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The study will involve all adult cancer patients presenting to the ED in TMH with a predominant complaint of severe pain.

Exclusion criteria

Exclusion criteria: The study will not consider those patients with delirious or incoherent behaviour, and those patients with red flag signs as bone fracture/impending fracture, epidural metastases, leptomeningeal metastases, infection, obstructed or perforated viscus (acute abdomen), any disease recurrence.

Design outcomes

Primary

MeasureTime frame
To analyze the effectiveness of implementing IV Morphine Titration Pain Protocol, in controlling severe pain (score above 7) in cancer patients.Timepoint: 1 year—

Secondary

MeasureTime frame
To ensure sustained pain relief in patients with severe cancer pain on a long-term basis.Timepoint: 1 year—

Countries

India

Contacts

Public ContactDrFebin Rahman

Tata Memorial Centre

pnj5@hotmail.com9869480429

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026